Tourmaline Bio Inc. (TRML)
NASDAQ: TRML
· Real-Time Price · USD
19.70
-0.20 (-1.01%)
At close: Jun 13, 2025, 3:59 PM
19.90
1.02%
After-hours: Jun 13, 2025, 04:25 PM EDT
-1.01% (1D)
| Bid | 17.2 |
| Market Cap | 506.06M |
| Revenue (ttm) | 40K |
| Net Income (ttm) | -82.87M |
| EPS (ttm) | -3.25 |
| PE Ratio (ttm) | -6.06 |
| Forward PE | -4.58 |
| Analyst | Buy |
| Ask | 20.43 |
| Volume | 135,279 |
| Avg. Volume (20D) | 363,261 |
| Open | 19.42 |
| Previous Close | 19.90 |
| Day's Range | 19.52 - 20.06 |
| 52-Week Range | 11.56 - 29.79 |
| Beta | 2.06 |
About TRML
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol TRML
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for TRML stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 weeks ago
-2.59%
TRML stock has given up its prior loss. Tourmaline...
Unlock content with
Pro Subscription
3 weeks ago
-2.59%
Tourmaline Bio shares are trading lower. The company announced topline results from its ongoing Phase 2 TRANQUILITY trial.
